Syndrome hémolytique et urémique atypique : pour qui l’éculizumab ?
Crossref DOI link: https://doi.org/10.1007/s13546-014-0928-3
Published Online: 2014-10-20
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Servais, A.
Hummel, A.
Legendre, C.
Text and Data Mining valid from 2014-10-20